These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 985031

  • 1. [Attempt at potentiation of the action of L-dopa on the secretion of growth hormone by benserazide, disulfiram and propranolol].
    Rochiccioli P, Enjaume P, Dutau G, Ribot C, Augier D.
    Arch Fr Pediatr; 1976 Jan; 33(1):55-66. PubMed ID: 985031
    [Abstract] [Full Text] [Related]

  • 2. [Growth hormone secretion induced by L-Dopa and a dopa decarboxylase inhibitor blocked by free fatty acids].
    Casanueva F, Villanueva L, Peñalva A, Barrionuevo JA, Vila T, Cabezas-Cerrato J.
    Rev Clin Esp; 1979 May 15; 153(3):221-4. PubMed ID: 482695
    [No Abstract] [Full Text] [Related]

  • 3. Growth hormone response in very short children.
    Palayew K, Crock P, Pianosi P, Coates A, Weitzner G, Schiffrin A.
    Clin Invest Med; 1991 Aug 15; 14(4):331-7. PubMed ID: 1782731
    [Abstract] [Full Text] [Related]

  • 4. [Action of a peripheral inhibitor of dopa-decarboxylase on the inhibition by L-DOPA of the hypothalamo-hypophyseo-adrenocortical system in man].
    Balestreri R, Bertolini S, Elicio N, Costa S.
    Boll Soc Ital Biol Sper; 1974 Jul 30; 50(12):832-7. PubMed ID: 4447697
    [No Abstract] [Full Text] [Related]

  • 5. Stimulation of growth hormone secretion by levodopa-propranolol in children and adolescents.
    Pediatrics; 1975 Aug 30; 56(2):262-6. PubMed ID: 169508
    [Abstract] [Full Text] [Related]

  • 6. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
    Silva MA, Mattern C, Häcker R, Tomaz C, Huston JP, Schwarting RK.
    Synapse; 1997 Dec 30; 27(4):294-302. PubMed ID: 9372552
    [Abstract] [Full Text] [Related]

  • 7. Propranolol enhancement of L-DOPA induced growth hormone stimulation.
    Camanni F, Massara F, Molinatti GM.
    Biomedicine; 1974 Jun 10; 21(6):241-3. PubMed ID: 4441586
    [No Abstract] [Full Text] [Related]

  • 8. Effect of L-dopa alone and with benserazide on the spontaneous activity of striatal neurones in normal and 6-hydroxydopamine-lesioned rats.
    Chang WY, Webster RA.
    Br J Pharmacol; 1997 May 10; 121(2):331-7. PubMed ID: 9154345
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone and IGF1 profile in short children with osteopetrosis.
    al Herbish AS, al Jarallah A, al Jurayyan NA, abo Bakr AM, al Rasheed SA, Mahdi AH.
    Clin Invest Med; 1994 Feb 10; 17(1):26-30. PubMed ID: 8174311
    [Abstract] [Full Text] [Related]

  • 10. [The effects of l-dopa administration on the prolactin levels in short-stature subjects].
    Saggese G, Cesaretti G, Carlotti C, Cioni C, Bracaloni C.
    Minerva Pediatr; 1992 Mar 10; 44(3):73-8. PubMed ID: 1518496
    [Abstract] [Full Text] [Related]

  • 11. Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
    Antonaccio MJ, Kerwin L.
    J Pharmacol Exp Ther; 1976 Feb 10; 196(2):380-8. PubMed ID: 1255483
    [Abstract] [Full Text] [Related]

  • 12. Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa.
    Eltayb A, Wadenberg ML, Svensson TH.
    Biol Psychiatry; 2005 Aug 15; 58(4):337-43. PubMed ID: 16102547
    [Abstract] [Full Text] [Related]

  • 13. Induction of aromatic-L-amino acid decarboxylase by decarboxylase inhibitors in idiopathic parkinsonism.
    Boomsma F, Meerwaldt JD, Man in 't Veld AJ, Hovestadt A, Schalekamp MA.
    Ann Neurol; 1989 Jun 15; 25(6):624-8. PubMed ID: 2742363
    [Abstract] [Full Text] [Related]

  • 14. L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment.
    Bergonzi P, Chiurulla C, Gambi D, Mennuni G, Pinto F.
    Acta Neurol Belg; 1975 Jun 15; 75(1):5-10. PubMed ID: 1202895
    [Abstract] [Full Text] [Related]

  • 15. [The L-DOPA-propranolol test for the evaluation of reserves in secretory growth hormone].
    Frisch H, Schober E, Stransky E.
    Wien Klin Wochenschr; 1983 Aug 26; 95(16):566-8. PubMed ID: 6649642
    [Abstract] [Full Text] [Related]

  • 16. [Potentialization of the action of tl-dopa on the secretion of growth hormone].
    Pombo M, Paz M.
    Arch Fr Pediatr; 1976 Aug 26; 33(7):714-5. PubMed ID: 999443
    [No Abstract] [Full Text] [Related]

  • 17. L-3,4-dihydroxyphenylalanine-induced c-Fos expression in the CNS under inhibition of central aromatic L-amino acid decarboxylase.
    Shimamura M, Shimizu M, Yagami T, Funabashi T, Kimura F, Kuroiwa Y, Misu Y, Goshima Y.
    Neuropharmacology; 2006 Jun 26; 50(8):909-16. PubMed ID: 16504219
    [Abstract] [Full Text] [Related]

  • 18. [Mechanisms of regulating monoamine oxidase activity in different brain regions].
    Petrenko SV, Balakleevskiĭ AI.
    Vopr Med Khim; 1980 Jun 26; 26(2):264-70. PubMed ID: 7456358
    [Abstract] [Full Text] [Related]

  • 19. [Central action of beta-phenylethylamine derivatives (10). Effect of L-Dopa on metaraminol induced motor activity (author's transl)].
    Shoji T, Tadano T, Kisara K.
    Nihon Yakurigaku Zasshi; 1977 May 26; 73(4):371-8. PubMed ID: 908541
    [Abstract] [Full Text] [Related]

  • 20. Propranolol-augmented, exercise-induced human growth hormone release.
    Maclaren NK, Taylor GE, Raiti S.
    Pediatrics; 1975 Nov 26; 56(5):804-7. PubMed ID: 1196739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.